Israel’s vaccine candidate set to launch Phase II clinical trial
The death toll from the coronavirus in Israel passed more than 3,000.
Hadassah-University Medical Center's Prof. Yossi Karko (left) and Hannah Drori, chief of the hospital’s clinical research center, administer Brilife vaccine to a volunteerUpdated: 
